Building access to the Regenstrief Institute is currently restricted. More on our coronavirus precautions.
See our coronavirus precautions.

Regenstrief Institute research scientist K. Clinton (Clint) Cary, M.D., MPH, has been accepted into the Evans Fellowship in Health Care Leadership program. This prestigious and competitive program provides full tuition for Dr. Cary to complete the Business of Medicine Physician MBA program from the Indiana University Kelley School of Business, along with extensive coaching, networking and mentoring opportunities.  

The program, led by IU School of Medicine and IU Health, aims to train physicians for administrative positions. It helps fellows develop a broader institutional perspective and enhance their leadership, understanding of business and ability to guide organizational change. The program was named in honor of Daniel F. Evans Jr., J.D., president emeritus of Indiana University Health. 

Dr. Cary’s research focuses on improving the health of patients with urologic cancers through health services and outcomes research in testis, bladder, and prostate cancer. He is a practicing urologist who provides direct medical and surgical care, with a specific focus on patients with testicular cancer and bladder cancer. 

In addition to his role as a research scientist at Regenstrief Institute, Dr. Cary is an associate professor of urology and director of Urologic Oncology Research within the Department of Urology at Indiana University School of Medicine and a physician with IU Health. 

About Regenstrief Institute 

Founded in 1969 in Indianapolis, the Regenstrief Institute is a local, national and global leader dedicated to a world where better information empowers people to end disease and realize true health. A key research partner to Indiana University, Regenstrief and its research scientists are responsible for a growing number of major healthcare innovations and studies. Examples range from the development of global health information technology standards that enable the use and interoperability of electronic health records to improving patient-physician communications, to creating models of care that inform practice and improve the lives of patients around the globe.  

Sam Regenstrief, a nationally successful entrepreneur from Connersville, Indiana, founded the institute with the goal of making healthcare more efficient and accessible for everyone. His vision continues to guide the institute’s research mission. 

MEDIA CONTACTS:
John Erickson
Regenstrief Institute
prteam@regenstrief.org
(317) 643-2313

Related News

Nov 16, 2021 • News
Study tackles reducing bladder cancer recurrence
National and international guidelines call for administration of postoperative immediate chemotherapy to reduce recurrence of non-muscle invasive bladder cancer. Yet this is done in less than half of cases. A new study led by Clint Cary, M.D., MPH, of the Regenstrief Institute and Indiana University School of Medicine, explores environmental barriers to implementation of these…
Continue Reading >
Nov 15, 2021 • News
No FIT: Colon cancer screening FIT doesn’t belong in emergency and inpatient settings
FIT and other cancer screening tests not designed for diagnosis A clinical research study from Indiana University School of Medicine and the Regenstrief Institute examines the use, in emergency and inpatient settings, of FIT (fecal immunochemical testing), which looks for blood in stool, a possible sign of colorectal cancer. The researchers conclude that FIT should…
Continue Reading >